1. Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma
   Mitsuru Miyachi et al, 2019, Medicine CrossRef
2. Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang
   Shaojun Chen et al, 2020, BMC Gastroenterol CrossRef
3. Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
   Chalirmporn Atasilp et al, 2020, Sci Rep CrossRef
4. Association of UGT1A1*6, UGT1A1*28, or ABCC2 c.3972C>T genetic polymorphisms with irinotecan-induced toxicity in Asian cancer patients: Meta-analysis.
   Chalirmporn Atasilp et al, 2022, Clin Transl Sci CrossRef